BAKER BROS ADVISORS LLC Insider Trading $INCY INCYTE CORP
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).
BAKER BROS ADVISORS LLC in INCYTE CORP
Trading Symbol: INCYIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 2,850,042 shares
Current Value: $336,817,964
Latest Transaction: Oct 02 2020
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC in INCYTE CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 02 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 317 | 0 | 29,313,809 | 29.3 M to 29.3 M (0.00 %) |
Oct 02 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 317 | 0 | 2,850,042 | 2.8 M to 2.9 M (+0.01 %) |
Jul 02 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 294 | 0 | 29,313,492 | 29.3 M to 29.3 M (0.00 %) |
Jul 02 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 294 | 0 | 2,849,725 | 2.8 M to 2.8 M (+0.01 %) |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 98.68 | 10,514 | 1,037,522 | 10,514 | |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | P | 102.55 | 1 | 103 | 29,313,198 | 29.3 M to 29.3 M (0.00 %) |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | P | 102.55 | 1 | 103 | 2,849,431 | 2.8 M to 2.8 M (0.00 %) |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,282 | 0 | 29,313,197 | 29.3 M to 29.3 M (0.00 %) |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,282 | 0 | 2,849,430 | 2.8 M to 2.8 M (+0.05 %) |
Apr 29 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 13.34 | 20,000 | 266,800 | 0 | |
Apr 29 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 13.34 | 20,000 | 266,800 | 0 | |
Apr 29 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 13.34 | 20,000 | 266,800 | 29,311,915 | 29.3 M to 29.3 M (+0.07 %) |
Apr 29 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 13.34 | 20,000 | 266,800 | 2,848,148 | 2.8 M to 2.8 M (+0.71 %) |
Apr 01 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 73.23 | 392 | 28,706 | 29,291,915 | 29.3 M to 29.3 M (0.00 %) |
Apr 01 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 73.23 | 392 | 28,706 | 2,828,148 | 2.8 M to 2.8 M (+0.01 %) |
Oct 02 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 74.23 | 364 | 27,020 | 29,291,207 | 29.3 M to 29.3 M (0.00 %) |
Oct 02 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 74.23 | 364 | 27,020 | 2,827,440 | 2.8 M to 2.8 M (+0.01 %) |
Jul 02 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 84.96 | 310 | 26,338 | 29,290,843 | 29.3 M to 29.3 M (0.00 %) |
Jul 02 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 84.96 | 310 | 26,338 | 2,827,076 | 2.8 M to 2.8 M (+0.01 %) |
Jun 07 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 220,141 | 0 | 281,190 | 61 K to 281.2 K (+360.60 %) |
Jun 07 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 220,141 | 0 | 278,773 | 58.6 K to 278.8 K (+375.46 %) |
Jun 07 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 692,706 | 0 | 0 | 692.7 K to 0 (-100.00 %) |
Jun 07 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 1,603,238 | 0 | 2,826,766 | 4.4 M to 2.8 M (-36.19 %) |
Apr 30 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 75.03 | 12,472 | 935,774 | 12,472 | |
Apr 30 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 75.03 | 12,472 | 935,774 | 12,472 | |
Apr 30 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 75.03 | 12,472 | 935,774 | 12,472 | |
Apr 30 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,520 | 0 | 812,602 | 811.1 K to 812.6 K (+0.19 %) |
Apr 30 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,520 | 0 | 29,290,533 | 29.3 M to 29.3 M (+0.01 %) |
Apr 30 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,520 | 0 | 4,430,004 | 4.4 M to 4.4 M (+0.03 %) |
Apr 02 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 86.01 | 220 | 18,922 | 811,082 | 810.9 K to 811.1 K (+0.03 %) |
Apr 02 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 86.01 | 220 | 18,922 | 29,289,013 | 29.3 M to 29.3 M (0.00 %) |
Apr 02 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 86.01 | 220 | 18,922 | 4,428,484 | 4.4 M to 4.4 M (0.00 %) |
Feb 27 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 2.80 | 20,000 | 56,000 | 0 | |
Feb 27 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 2.80 | 20,000 | 56,000 | 0 | |
Feb 27 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 2.80 | 20,000 | 56,000 | 29,288,793 | 29.3 M to 29.3 M (+0.07 %) |
Feb 27 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 2.80 | 20,000 | 56,000 | 4,428,264 | 4.4 M to 4.4 M (+0.45 %) |
Jan 02 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 63.59 | 298 | 18,950 | 810,862 | 810.6 K to 810.9 K (+0.04 %) |
Jan 02 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 63.59 | 298 | 18,950 | 29,268,793 | 29.3 M to 29.3 M (0.00 %) |
Jan 02 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 63.59 | 298 | 18,950 | 4,408,264 | 4.4 M to 4.4 M (+0.01 %) |
Jul 03 2018 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 67.00 | 283 | 18,961 | 810,289 | 810 K to 810.3 K (+0.03 %) |
Jul 03 2018 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 67.00 | 283 | 18,961 | 29,268,220 | 29.3 M to 29.3 M (0.00 %) |
Jul 03 2018 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 67.00 | 283 | 18,961 | 4,407,691 | 4.4 M to 4.4 M (+0.01 %) |
Apr 02 2018 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 83.33 | 228 | 18,999 | 790,006 | 789.8 K to 790 K (+0.03 %) |
Apr 02 2018 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 83.33 | 228 | 18,999 | 29,247,937 | 29.2 M to 29.2 M (0.00 %) |
Apr 02 2018 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 83.33 | 228 | 18,999 | 4,387,408 | 4.4 M to 4.4 M (+0.01 %) |
Jan 03 2018 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 94.71 | 200 | 18,942 | 789,778 | 789.6 K to 789.8 K (+0.03 %) |
Jan 03 2018 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 94.71 | 200 | 18,942 | 29,247,709 | 29.2 M to 29.2 M (0.00 %) |
Jan 03 2018 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 94.71 | 200 | 18,942 | 4,387,180 | 4.4 M to 4.4 M (0.00 %) |
Oct 03 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 116.74 | 162 | 18,912 | 789,578 | 789.4 K to 789.6 K (+0.02 %) |
Oct 03 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 116.74 | 162 | 18,912 | 29,247,509 | 29.2 M to 29.2 M (0.00 %) |
Oct 03 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 116.74 | 162 | 18,912 | 4,386,980 | 4.4 M to 4.4 M (0.00 %) |
Sep 08 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | P | 132.00 | 2,029 | 267,828 | 789,416 | 787.4 K to 789.4 K (+0.26 %) |
Sep 08 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | P | 132.00 | 85,402 | 11,273,064 | 29,247,347 | 29.2 M to 29.2 M (+0.29 %) |
Sep 08 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | P | 132.00 | 12,569 | 1,659,108 | 4,386,818 | 4.4 M to 4.4 M (+0.29 %) |
May 31 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 134.38 | 15,000 | 2,015,700 | 15,000 | |
Apr 28 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 7.26 | 20,000 | 145,200 | 0 | |
Apr 28 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 7.26 | 20,000 | 145,200 | 0 | |
Apr 28 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 7.26 | 20,000 | 145,200 | 0 | |
Apr 28 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 7.26 | 20,000 | 145,200 | 787,237 | 767.2 K to 787.2 K (+2.61 %) |
Apr 28 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 7.26 | 20,000 | 145,200 | 29,161,795 | 29.1 M to 29.2 M (+0.07 %) |
Apr 28 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 7.26 | 20,000 | 145,200 | 4,374,099 | 4.4 M to 4.4 M (+0.46 %) |
Apr 04 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 133.67 | 142 | 18,981 | 767,237 | 767.1 K to 767.2 K (+0.02 %) |
Apr 04 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 133.67 | 142 | 18,981 | 29,141,795 | 29.1 M to 29.1 M (0.00 %) |
Apr 04 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 133.67 | 142 | 18,981 | 4,354,099 | 4.4 M to 4.4 M (0.00 %) |
Page: 1